Publications
5674 Results
- Journal / Conference
- Journal of Clinical Oncology 31(4):440-447
- Year
- 2013
- Research Committee(s)
- Leukemia
- PMID
- PMID23233702
- PMC
- PMC3731920
Impact of age on outcomes after initial therapy with chemotherapy and different chemoimmunotherapy regimens in patients with chronic lymphocytic leukemia: results of sequential cancer and leukemia group B studies
- Journal / Conference
- International Journal of Radiation Oncology * Biology * Physics 87(2):Supplement, p. S82; ASTRO annual meeting Sept. 22-25, 2013, Atlanta, GA), oral presentation;
- Year
- 2013
- Research Committee(s)
- Genitourinary
- Study Number(s)
- SWOG-8710 (INT-0080) (EST-1887) (CALGB-8891)
Robust risk stratification model predicts local-regional recurrence after radical cystectomy in different patient cohorts
- Journal / Conference
- Journal of the National Cancer Institute 105(23):1789-1798;
- Year
- 2013
- Research Committee(s)
- Gastrointestinal
- PMID
- PMID24231454
- PMC
- PMC384898
- Study Number(s)
- C89803
Predictive and prognostic analysis of PIK3CA mutation in stage III colon cancer intergroup trial
- Journal / Conference
- Clinical Cancer Research, 19(10):2646-2656;
- Year
- 2013
- Research Committee(s)
- Brain, Breast, Gastrointestinal, Gynecologic, Lung, Lymphoma, and Myeloma
- PMID
- PMID23669424
- PMC
- PMC4131693
- Study Number(s)
- S0001, S0124, SWOG-8797 (INT-0107) (GOG-109) (RTOG-91-12), SWOG-9008 (INT-0116) (RTOG-9018) (NCCTG-90-41-51) (ECOG-6290) (CALGB-9195), SWOG-9308, SWOG-9313, SWOG-9321, SWOG-9415 (INT-0153) (CALGB-9498) (ECOG-S9415) (NCCTG-S9415), SWOG-9438, SWOG-9509
Modeling the relationship between progression-free survival and overall survival: the phase 2/3 trial
- Journal / Conference
- Clinical Cancer Research 19(5):1281-1289
- Year
- 2013
- Research Committee(s)
- Breast
- PMID
- PMID23340303
- PMC
- PMC3594423
- Study Number(s)
- CTSU/E2100
Prognostic and predictive value of tumor vascular endothelial growth factor gene amplification in metastatic breast cancer treated with paclitaxel with and without bevacizumab; results from ECOG 2100 trial
- Journal / Conference
- Leukemia 27(4):780-91
- Year
- 2013
- Research Committee(s)
- Myeloma
- PMID
- PMID23288300
- PMC
- n/a - review article
Plasma cell leukemia: consensus statement on diagnostic requirements, response criteria and treatment recommendations by the International Myeloma Working Group
- Journal / Conference
- European Urology, 63(4):717-723
- Year
- 2013
- Research Committee(s)
- Genitourinary
- PMID
- PMID23206856
- PMC
- PMC4127896
- Study Number(s)
- S0031, S0306
Time from prior chemotherapy enhances prognostic risk grouping in the second-line setting of advanced urothelial carcinoma: a retrospective analysis of pooled, prospective Phase 2 trials
- Journal / Conference
- Annals of Thoracic Surgery 95(2):750-756
- Year
- 2013
- Research Committee(s)
- Lung
- PMID
- PMID23336898
- PMC
- Reviews not within the scope of the Public Access Policy
Cooperative group clinical trials in general thoracic surgery: report from the 2012 Robert Ginsberg Clinical Trials Meeting of the General Thoracic Surgical Club
- Journal / Conference
- Society for Clinical Trials Annual Meeting (May 19-22, 2013, Boston, MA), poster presentation
- Year
- 2013
- Research Committee(s)
- Prevention, Screening, and and Surveillance
- Study Number(s)
- S0000
Factors associated with retention of African-American and white participants in a prostate cancer prevention trial
- Journal / Conference
- Journal of Clinical Oncology 31(suppl; abstr 8515); ASCO annual meeting 2013, oral presentation
- Year
- 2013
- Research Committee(s)
- Myeloma
- Study Number(s)
- S0120